Article Text

Download PDFPDF
Fast relapse upon discontinuation of tumour necrosis factor blocking therapy in patients with peripheral spondyloarthritis

Statistics from


  • Contributors All authors were involved in drafting the article or revising it critically for important intellectual content, and all authors approved the final version to be published. Study conception and design: JEP and DLB. Data acquisition: JEP and TFH. Analysis and interpretation of the data: JEP and DLB.

  • Funding None.

  • Competing interests None.

  • Patient consent All patients gave written informed consent.

  • Data sharing statement Data of our research article are available upon request. Additional data of this cohort are expected to be published in the future.

  • Ethics approval Approved by the Medical Ethics Committee of the Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.